Call 413.540.1234 to
schedule an appointment
CONCERN/EAP: 413.534.2625
Billing questions? Call: 413.540.1212
CRISIS: 413.733.6661

Health Policy & Advocacy
Resources
Basic InformationMore InformationLatest News
Food Stamp Benefits May Lower Health Care CostsFrequent Blood Donations Safe for Some, But Not AllDrone Sets New Record for Transporting Blood SamplesGun Injuries Add Millions of Dollars to Hospital CostsACP Does Not Support Legalization of Assisted SuicideAAP: Few Doctors Provide Firearm Injury Prevention Info in ER9 of 10 Docs Unprepared to Prescribe MarijuanaThis Mistake Can Cost Athletes' Lives in Cardiac ArrestDrills Assess ER Response to Communicable DiseaseDo Nursing Home Workers Change Gloves Often Enough?Minorities Exposed to Dirtier Air, U.S. Study FindsPhysicians Tweeting About Drugs May Have Conflict of Interest'Science Spin' Found Prevalent in Biomedical LiteratureHealth Tip: Overcoming the Obesity EpidemicU.S. Military Surgeons Helped More Than 6,000 Afghan AdultsWhat You Can Do to Help Fight the Opioid EpidemicAre Physicians Obligated to Help on Planes?Median Cost of Cancer Drug Development $648.0 MillionDoes Study Claim a Cure? Beware of Scientific 'Spin'Vaccine Campaign in Poor Countries to Save 20 Million LivesThird Dose of MMR Vaccine Could Help Curb Mumps OutbreaksDocs Should Be Aware of Family Beliefs Regarding NondisclosureIncrease in Medical Exemptions From Immunization in CaliforniaMailed Invitations Increase CRC Screening CompletionMany Americans Getting Medical Care They Don't NeedInsurer Aetna's Envelopes Revealed Customers' HIV StatusHealth Groups Demand 'R' Rating for Movies That Show SmokingGoogle Search for 'Depression' Now to Provide Screening TestPatients' Hearing Loss May Mean Poorer Medical CareFDA May Limit 'Risk Info' in Direct-to-Consumer TV Drug AdsFDA Announces Recall of Some Liquid Pharmaceutical ProductsIs FDA Taking Close Enough Look at Fast-Tracked Drugs?Steep Price Hikes Led to Drop in Use of 2 Heart Drugs at U.S. HospitalsAPA: Medical Discrimination Based on Size Stresses Patients2 of 3 U.S. Patients Keep Unused Painkillers After SurgeryMedical Reality Catches Up to Science FictionFDA Looks to Reduce Nicotine in CigarettesAHA Hands-Only CPR Training Kiosks Available at More Airports$100 Sweetens the Pot for a ColonoscopyJust a Few Vaccine Refusers Could Endanger ManyASCO Addresses Cancer Drug PricingHigh Court Rules Against Interstate Medical LiabilityFewer U.S. Dollars Spent on Cardiac Arrest Research: StudyPainkiller Prescriptions More Prone to Errors If HandwrittenFDA Panel OKs What May Soon Be First Gene Therapy Approved in U.S.Walking Rates Are Key to a Country's Obesity LevelsDocs Should Counsel Even Healthy People on Diet, Exercise, Experts SayHealth Service Use Unchanged From 1996-1997 to 2011-2012Easier Colon Exam Boosts Screening, But Insurers May Not PayMore U.S. Patients Are Recording Their Doctor Visits
Questions and AnswersLinksBook Reviews
Related Topics

Price Transparency Intervention Doesn't Cut Lab Test Orders


HealthDay News
Updated: Apr 24th 2017

new article illustration

MONDAY, April 24, 2017 (HealthDay News) -- Clinician test-ordering behavior is not affected by displaying Medicare allowable fees in the electronic health record at the time of order entry, according to a study published online April 21 in JAMA Internal Medicine to coincide with the annual meeting of the Society of General Internal Medicine, held from April 19 to 22 in Washington, D.C.

Mina S. Sedrak, M.D., from the City of Hope Comprehensive Cancer Center in Duarte, California, and colleagues examined the effect of displaying Medicare allowable fees for inpatient laboratory tests on clinician ordering behavior over one year. Data were included for 98,529 patients involved in 142,921 hospital admissions between April 2014 and April 2016. A one-year intervention of displaying Medicare allowable fees in the electronic health record at the time of order entry was compared with a one-year preintervention period.

The researchers found that in adjusted analyses, there were no significant changes in overall test-ordering behavior for the intervention versus the control group over time (0.05 tests ordered per patient-day; 95 percent confidence interval [CI], −0.002 to 0.09; P = 0.06) or associated fees (24 cents per patient-day; 95 percent CI, −42 cents to 91 cents; P = 0.47). Based on patient intensive care unit (ICU) stay, there was a small but significant difference in tests ordered per patient-day (patients with ICU stay: −0.16; 95 percent CI, −0.31 to −0.01; P = 0.04; patients without ICU stay: 0.13; 95 percent CI, 0.08 to 0.17; P < 0.001) and in the magnitude of associated fees.

"Displaying Medicare allowable fees for inpatient laboratory tests did not lead to a significant change in overall clinician ordering behavior or associated fees," the authors write.

One author disclosed ties to Catalyst Health.

Abstract/Full Text
Editorial
More Information